- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06530277
REMINDer - a Digital Environmental Enrichment Intervention (REMINDer)
Feasibility and Preliminary Efficacy of a 12-weeks Digital Environmental Enrichment Intervention in Cognitively Unimpaired Older Adults (REMINDer)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Increasing life expectancy and associated age-related diseases, such as Alzheimer's disease, are considered a global challenge for society. Multiple physical, cognitive, and psychosocial risk factors can increase the risk of developing Alzheimer's disease. To effectively maintain mental health and well-being in older adults, multimodal, low-threshold, cost-effective, lifestyle-based intervention strategies that simultaneously and sustainably promote cognitive, physical, psychological, and social functioning in the older population are needed.
Objective: The primary objective of this randomized, controlled pilot study is to assess the feasibility and effectiveness of a multimodal intervention program delivered in a digital telehealth environment to improve overall mental and physical well-being of older adults.
Methods: The REMINDer study is a monocentric, randomized, assessor-blinded, controlled pilot study with a 6-week intervention period (2 hours per week). The study includes a digital multimodal intervention called REMINDer (Environmental Enrichment Intervention to Prevent Dementia - electronic intervention). This program is specifically designed for older adults and includes music, dance-based movement, and mind (specifically mindfulness) activities that are simultaneously trained to activate and strengthen brain resources and resilience to dementia. The intervention will be delivered in a digital telehealth environment (via an established videoconferencing platform) and compared to a 6-week passive control (waitlist with delayed intervention, AB-BA design) in a cross-over study design. For this first pilot study, a total of n = 50 cognitively unimpaired older adults will be recruited from the general population (spouses will be allowed in the same group and analyses will be controlled accordingly). Participants will be randomized to the two intervention groups using block randomization, stratified by age and sex, with a 1:1 allocation ratio.
Results: The primary outcomes of the study are feasibility, operationalized by adherence rates, and effectiveness of the intervention. Adherence per participant will be assessed by the number of sessions attended relative to the total number of sessions. Effectiveness will be assessed by the change in self-reported overall mental and physical well-being, operationalized by the Short-Form Health Survey (SF-12), measured at baseline (t1), post-intervention (t2), and follow-up (t3). Secondary outcomes will include changes in self-reported cognitive, motor, sensory, emotional/affective, social, and lifestyle behaviors, assessed at baseline, post-intervention, and follow-up using digital assessments.
Discussion: This pilot study will provide preliminary evidence on the feasibility and effectiveness of a digital multimodal intervention (REMINDer) to improve mental health and well-being in older adults. The results of this pilot study will inform a larger intervention trial aimed at improving multiple health risk factors for dementia in older populations at increased risk for Alzheimer's disease.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Saxony
-
Dresden, Saxony, Germany, 01307
- German Center for Neurodegenerative Diseases (DZNE), Dresden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Retired adults aged between 60 and 80 years
- Fluency in the German language
- Cognitively unimpaired, as assessed via the Six-Item Screener (SIS) ≥ 4 points (out of 6)
- Access to wireless internet connection and a digital device with speakers, screen, and camera at home
- Access to a personal email address
- Sufficient in-home space
- Availability throughout the study and its measurement time points
- Ability to provide written informed consent
- Spouses (must be in the same group and each participate in the intervention individually via their own device and in independent rooms; this fact is considered accordingly in the analyses)
Exclusion Criteria:
- Regular rigorous physical exercise as defined by regular aerobic exercise (> 1.5 hours/week) during the last 6 months
- Regular prior experience (> 1 hour/week) with tai chi, dance-movement, or other mind-body practices during the last 6 months
- Disabilities that limit participation in online moment programs: Presence of physical ineligibility or mobility restrictions through a history of falls, not being able to walk, reliance on a walking aid
- Severe uncorrected auditory or visual impairments that limit the ability to listen to online instructions or to observe online movements
- Diagnosis of cognitive impairment and any type of dementia
- Diagnosis of motor disorders (e.g. Parkinson's disease, multiple sclerosis)
- History of cerebral disease (e.g. tumor)
- Severe neurological disorders (e.g. epilepsy)
- Diagnosis of psychiatric disorders (e.g. depression)
- Other chronic medical disorders that limit physical activity (e.g. advanced cardiac or respiratory disease, severe hypertension)
- Substance abuse (excessive smoking, alcohol consumption, drug abuse)
- Current participation in another research study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention, no intervention (AB)
Beginning with the digital multimodal intervention (REMINDer) and then transitioning to a no intervention phase (sequence: AB).
|
REMINDer adapts the REMIND program (Nicotra et al., 2022) for telehealth, integrating cognitive, motor, sensory, emotional, and social stimulation through "music, dance-based movement, and mindfulness".
The program consists of 2 online sessions/week for 60 minutes each over 6 weeks, led by trained facilitators experienced in dance movement therapy and mindfulness exercises.
Sessions are divided into welcome/warm-up (10 min), training (40 min), and relaxation/feedback (10 min) phases.
Using a structured manual, participants perform exercises that address the program's multimodal stimulation.
The REMINDer program is delivered in a group setting via an online videoconferencing system.
The "intervention, no intervention" (AB) group undergoes the training program between t1 and t2 and then resumes their normal lifestyle from t2 to t3.
The "no intervention, intervention" group (BA) maintains its normal lifestyle from t1 to t2 and then participates in the training program from t2 to t3.
|
|
Experimental: No intervention, intervention (BA)
Starting with a no intervention phase and subsequently moving to the digital multimodal intervention (REMINDer) (sequence: BA).
|
REMINDer adapts the REMIND program (Nicotra et al., 2022) for telehealth, integrating cognitive, motor, sensory, emotional, and social stimulation through "music, dance-based movement, and mindfulness".
The program consists of 2 online sessions/week for 60 minutes each over 6 weeks, led by trained facilitators experienced in dance movement therapy and mindfulness exercises.
Sessions are divided into welcome/warm-up (10 min), training (40 min), and relaxation/feedback (10 min) phases.
Using a structured manual, participants perform exercises that address the program's multimodal stimulation.
The REMINDer program is delivered in a group setting via an online videoconferencing system.
The "intervention, no intervention" (AB) group undergoes the training program between t1 and t2 and then resumes their normal lifestyle from t2 to t3.
The "no intervention, intervention" group (BA) maintains its normal lifestyle from t1 to t2 and then participates in the training program from t2 to t3.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: Adherence to the intervention
Time Frame: from baseline (t1) to the end of the 6-weeks intervention (t2)
|
Assessed by the number of sessions attended in relation to the total number of sessions ([number of sessions attended / total number of sessions] * 100).
|
from baseline (t1) to the end of the 6-weeks intervention (t2)
|
|
Effectiveness: Change in overall mental and physical well-being
Time Frame: from baseline (t1) to the end of the 6-weeks intervention (t2)
|
Assessed by the Short-Form-Health Survey (SF-12), range 0 to 100, higher scores indicate greater mental and physical well-being.
|
from baseline (t1) to the end of the 6-weeks intervention (t2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: reach
Time Frame: End of 6-week-intervention (t2)
|
[participants enrolled / participants screened and eligible] * 100
|
End of 6-week-intervention (t2)
|
|
Feasibility: retention rate
Time Frame: 12 weeks post baseline (6 weeks post intervention) (t3)
|
[participants completing t3 / participants enrolled] * 100
|
12 weeks post baseline (6 weeks post intervention) (t3)
|
|
Feasibility: dropout rate
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the number of participants who did not complete the intervention and follow-up period divided by the total number of participants that underwent the randomisation process.
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Feasibility: Change in credibility and acceptance
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Credibility Expectancy Questionnaire (CEQ), instruction adapted, range 1 to 9, higher scores indicating higher credibility and acceptance
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in cognitive ability: subjective cognition function
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Everyday Cognition Scales (ECog-12), short form, instruction adapted, range 1 to 4 (mean), higher scores indicate higher subjective cognitive impairment / worse cognitive state
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in cognitive ability: objective cognitive function
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Consortium to Establish a Registry for Alzheimer's Disease (CERAD): word list learning.
Instruction adapted, range subscale wordlist learning 0 to 10, higher scores indicate better memory function
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in motor ability: frailty
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Tilburg frailty indicator (TFI), range 0 to 15, higher scores indicate higher frailty.
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in sensory ability: interoceptive awareness
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Multidimensional Assessment of Interoceptive Awareness (MAIA), subscale awareness, range 0 to 5, higher scores indicate more positive body awareness
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in sensory ability: self-perceived bodily abilities
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Body Self-Efficacy Scale (BSE), range 1 to 5, higher scores indicate greater feelings associated with the four domains: guilt, shame, authentic pride and hubristic pride
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in well-being: psychological well-being
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Ryff's Psychological Well-Being Scales (PWB), short form (18 items), range 1 to 7, higher scores indicate greater well-being.
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in well-being: general well-being
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Heidelberg State Inventory (HSI-24), range 1 to 5, higher scores indicate higher well-being
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in positive emotion: life-satisfaction
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the General Life Satisfaction Short Scale (L1), range 0 to 10, higher scores indicate greater satisfaction with life
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in positive emotion: mindfulness
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Freiburg Mindfulness Inventory (German: FFA), range 1 to 4, higher scores indicate more mindfulness
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in negative emotion: perceived stress
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Perceived Stress Scale (PSS-10), range 1 to 5, higher scores indicate greater levels of perceived stress
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in negative emotion: anxiety
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the State-Trait Anxiety Inventory (STAI-5), short form, range 1 to 4, higher scores indicate higher anxiety
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in social integration / loneliness
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the German Version of the UCLA Three-item loneliness scale (LS-S), range 1 to 5, higher scores indicate less social integration / more loneliness
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in social connectedness with others
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Inclusion of Other in the Self (IOS), range 1 to 7, higher scores indicate more overlap indicating higher social connectedness
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in lifestyle: social activity
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Lubben Social Network Scale (LSNS-6), range 0 to 30, higher scores indicate bigger active and intimate networks of family and friends
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in lifestyle: physical activity
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Physical Activity Scale for the Elderly (PASE), minimum score 0, higher scores indicate greater physical activity
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
|
Change in lifestyle: sleep quality
Time Frame: a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Assessed by the Jenkins Sleep Scale 4 (JSS-4), range 0 to 20, higher scores indicate more sleep problems
|
a) From baseline to the end of 6-week-intervention (t2) b) From baseline to 12 weeks (t3)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Miranka Wirth, Dr. habil. Dipl.-Psych., German Center for Neurodegenerative Diseases (DZNE), Dresden
- Principal Investigator: Olga M. Klimecki, PD Dr., German Center for Neurodegenerative Diseases (DZNE), Dresden
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SR-EK-477112023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on REMINDer (A digital environmental enrichment intervention)
-
Windward Islands Research and Education FoundationNational Institutes of Health (NIH); Stanford University; St. George's UniversityCompletedNeurocognitive Deficit | Zika Virus Infection | Development, Child | Neurodevelopmental AbnormalityGrenada
-
Windward Islands Research and Education FoundationGrand Challenges Canada; St. George's University; GRENCASECompletedDevelopment, Child | Behavior, Child | Neurocognition, ChildGrenada
-
Eskisehir Osmangazi UniversityNot yet recruitingPreterm BirthTurkey (Türkiye)
-
Sakarya Yenikent State HospitalNot yet recruitingPrimary Open-Angle Glaucoma (POAG)
-
University of MalayaRecruitingTuberculosis (TB)Malaysia
-
Queen Mary University of LondonUniversity of Nottingham; University of Edinburgh; University of Cambridge; National... and other collaboratorsCompletedAsthma Intermittent, UncontrolledUnited Kingdom
-
University Medical Center GroningenCompleted
-
Queen Mary University of LondonUniversity of Nottingham; University of Edinburgh; University of Cambridge; National... and other collaboratorsRecruitingAsthma Intermittent, UncontrolledUnited Kingdom
-
Royal Marsden NHS Foundation TrustKing's College LondonRecruitingProstate Cancer | Prostate Cancer (Diagnosis)United Kingdom